FDA Approves Zepbound: New Weight Loss Medication for Chronic Obesity

Published on November 11, 2023, 12:48 am

The Food and Drug Administration (FDA) has recently approved a new weight loss medication called Zepbound, developed by pharmaceutical company Eli Lilly. This drug is a brand name for tirzepatide, which has already been approved to treat Type 2 diabetes under the name Mounjaro.

Zepbound is specifically designed to target chronic obesity in adults. It works by reducing appetite and improving the body’s ability to break down sugar and fat. The medication is administered through injections in the thigh, stomach, or arm.

According to the FDA, Zepbound should be used in combination with a reduced-calorie diet and increased physical activity. Obesity and overweight are serious conditions that can lead to various health issues such as heart disease, stroke, and diabetes. The approval of Zepbound aims to address this unmet medical need.

To qualify for Zepbound treatment, individuals must have a body mass index (BMI) of 30 or greater, indicating obesity. Additionally, those with a BMI of 27 or higher may be eligible if they have at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.

It’s worth noting that Zepbound is expected to be available in the United States by the end of the year. However, it comes at a price of $1,059 without insurance coverage.

Mounjaro and Zepbound are both brand names for tirzepatide. They belong to the same class of medications as Ozempic and Wegovy (brand names for semaglutide). These drugs work in the brain to impact satiety and have gained popularity among Hollywood celebrities and beyond for their potential weight loss effects.

The approval of Zepbound provides another option for individuals struggling with chronic obesity. However, it’s important to remember that any weight loss medication should be used in conjunction with a balanced diet and regular exercise regimen. It’s always advisable to consult with a healthcare professional before starting any new treatment.

Remember, living a healthy lifestyle is key to maintaining overall well-being. Regular exercise, a balanced diet, and appropriate medical interventions can help individuals manage their weight effectively and reduce the risk of obesity-related health complications.